Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE)-- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Materialise NV (NASDAQ:MTLS) is among the best 3D printing stocks to buy according to hedge funds. Materialise NV (NASDAQ:MTLS) continues to execute on its €30 million share buyback program it ...
The latest update is out from Materialise ( (MTLS)). On February 23, 2026, Materialise NV disclosed an update on its previously announced EUR 30 million share buyback program, under which an ...
LEVUEN, Belgium (AP) — LEVUEN, Belgium (AP) — Materialise NV (MTLS) on Thursday reported profit of $7.3 million in its fourth quarter. On a per-share basis, the Levuen, Belgium-based company said it ...
(1) Acquisition-related expenses of business combinations represent expenses incurred in connection with the acquisition of Feops. The articles, information, and content displayed on this webpage may ...
An announcement from Materialise ( (MTLS)) is now available. On November 14, 2025, Materialise NV held an Extraordinary Shareholders’ Meeting where all proposed resolutions were approved. These ...
Koen Berges stated that "revenues from our Software and Manufacturing segments continue to be impacted by macroeconomic headwinds," and noted, "revenue in both segments declined by 7% and 17%, ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Materialise ( (MTLS)) has issued an ...
At a time when healthcare systems are under pressure to increase efficiency while delivering tailored outcomes, Belgian company Materialise is making a calculated push to bridge that divide. A ...
Image source: The Motley Fool. Materialise (NASDAQ:MTLS) delivered a quarter marked by revenue contraction in Non-Medical segments, but offset by record Medical segment growth and doubled-down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results